NCT07502495 clinical trial report covering Icovamenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503639 clinical trial report covering HRS-4642, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600121505 clinical trial report covering Olaparib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503379 clinical trial report covering Docetaxel, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07502872 clinical trial report covering Tafasitamab-Cxix, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503886 clinical trial report covering Isocyclosporin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503873 clinical trial report covering Ublituximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503756 clinical trial report covering JS-212, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07502508 clinical trial report covering Icovamenib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503340 clinical trial report covering Ocrelizumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503405 clinical trial report covering Viroksavir, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07503561 clinical trial report covering AIC-468, Phase 2, endpoints, sponsor, geography, readout timing and development white space.